As per this agreement, earnings will accrue to the benefit of Cardiovascular Sciences.
Eric Edelmann, president of Medical technologies, said: “With all the recent advances and impressive data that have become available on nutritionals, supplements and anti-oxidants, it is appropriate and even exciting to team up with a company like Cardiovascular Sciences to bring our own product line of quality and effective health products to market.”